The results showed that a significant difference in protein levels between PCa and BPH showed FABP5 and ENO1, with FABP5 showing increased levels in PCa (p = 0.019) and ENO1 showing the opposite (p = 0.015). Here, FABP5 is linked to benign prostatic hyperplasia.